Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Nokin MJ, Bellier J, Durieux F, Peulen O, et al. Breast Cancer Res 2025;27:99.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nokin MJ, Bellier J, Durieux F, Peulen O, et al. Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Res 2025;27:99.
PMID: 40468322